Shopping Cart
- Remove All
- Your shopping cart is currently empty
ABT-639 is a potent and selective T-type calcium channel blocker.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $44 | In Stock | |
2 mg | $64 | In Stock | |
5 mg | $98 | In Stock | |
10 mg | $178 | In Stock | |
25 mg | $355 | In Stock | |
50 mg | $572 | In Stock | |
100 mg | $822 | In Stock | |
500 mg | $1,690 | In Stock |
Description | ABT-639 is a potent and selective T-type calcium channel blocker. |
In vitro | ABT-639 is significantly less active at other Ca2+ channels (e.g. Cav1.2 and Cav2.2) (IC50 > 30 μM). ABT-639 has high oral bioavailability (%F = 73), low protein binding (88.9%) and a low brain:plasma ratio (0.05:1) in rodents. |
In vivo | Following oral administration ABT-639 produces dose-dependent antinociception in a rat model of knee joint pain (ED50 = 2 mg/kg, p.o.). ABT-639 (10-100 mg/kg, p.o.) also increases tactile allodynia thresholds in multiple models of neuropathic pain. The antinociceptive profile of ABT-639 provides novel insights into the role of peripheral T-type (Cav3.2) channels in chronic pain states. |
Alias | ABT 639 |
Molecular Weight | 455.91 |
Formula | C20H20ClF2N3O3S |
Cas No. | 1235560-28-7 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 55 mg/mL (120.64 mM) | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.